 | • レポートコード：QYR2104Z0029 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・後天性血友病A治療の市場動向 ・企業の競争状況、市場シェア ・後天性血友病A治療の種類別市場規模（200IU、250IU） ・後天性血友病A治療の用途別市場規模（病院、薬局） ・後天性血友病A治療の北米市場規模2016-2027（アメリカ、カナダ） ・後天性血友病A治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・後天性血友病A治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・後天性血友病A治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・後天性血友病A治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi） ・結論 |
ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer.
Market Analysis and Insights: Global Acquired hemophilia A Treatment Market
The global Acquired hemophilia A Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acquired hemophilia A Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acquired hemophilia A Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acquired hemophilia A Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acquired hemophilia A Treatment market.
Global Acquired hemophilia A Treatment Scope and Market Size
Acquired hemophilia A Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acquired hemophilia A Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
200IU
250IU
Segment by Application
Hospital
Pharmacy
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired hemophilia A Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 200IU
1.2.3 250IU
1.3 Market by Application
1.3.1 Global Acquired hemophilia A Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acquired hemophilia A Treatment Market Perspective (2016-2027)
2.2 Acquired hemophilia A Treatment Growth Trends by Regions
2.2.1 Acquired hemophilia A Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acquired hemophilia A Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acquired hemophilia A Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acquired hemophilia A Treatment Industry Dynamic
2.3.1 Acquired hemophilia A Treatment Market Trends
2.3.2 Acquired hemophilia A Treatment Market Drivers
2.3.3 Acquired hemophilia A Treatment Market Challenges
2.3.4 Acquired hemophilia A Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acquired hemophilia A Treatment Players by Revenue
3.1.1 Global Top Acquired hemophilia A Treatment Players by Revenue (2016-2021)
3.1.2 Global Acquired hemophilia A Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acquired hemophilia A Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acquired hemophilia A Treatment Revenue
3.4 Global Acquired hemophilia A Treatment Market Concentration Ratio
3.4.1 Global Acquired hemophilia A Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired hemophilia A Treatment Revenue in 2020
3.5 Acquired hemophilia A Treatment Key Players Head office and Area Served
3.6 Key Players Acquired hemophilia A Treatment Product Solution and Service
3.7 Date of Enter into Acquired hemophilia A Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acquired hemophilia A Treatment Breakdown Data by Type
4.1 Global Acquired hemophilia A Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acquired hemophilia A Treatment Forecasted Market Size by Type (2022-2027)
5 Acquired hemophilia A Treatment Breakdown Data by Application
5.1 Global Acquired hemophilia A Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acquired hemophilia A Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acquired hemophilia A Treatment Market Size (2016-2027)
6.2 North America Acquired hemophilia A Treatment Market Size by Type
6.2.1 North America Acquired hemophilia A Treatment Market Size by Type (2016-2021)
6.2.2 North America Acquired hemophilia A Treatment Market Size by Type (2022-2027)
6.2.3 North America Acquired hemophilia A Treatment Market Size by Type (2016-2027)
6.3 North America Acquired hemophilia A Treatment Market Size by Application
6.3.1 North America Acquired hemophilia A Treatment Market Size by Application (2016-2021)
6.3.2 North America Acquired hemophilia A Treatment Market Size by Application (2022-2027)
6.3.3 North America Acquired hemophilia A Treatment Market Size by Application (2016-2027)
6.4 North America Acquired hemophilia A Treatment Market Size by Country
6.4.1 North America Acquired hemophilia A Treatment Market Size by Country (2016-2021)
6.4.2 North America Acquired hemophilia A Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Acquired hemophilia A Treatment Market Size (2016-2027)
7.2 Europe Acquired hemophilia A Treatment Market Size by Type
7.2.1 Europe Acquired hemophilia A Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acquired hemophilia A Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acquired hemophilia A Treatment Market Size by Type (2016-2027)
7.3 Europe Acquired hemophilia A Treatment Market Size by Application
7.3.1 Europe Acquired hemophilia A Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acquired hemophilia A Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acquired hemophilia A Treatment Market Size by Application (2016-2027)
7.4 Europe Acquired hemophilia A Treatment Market Size by Country
7.4.1 Europe Acquired hemophilia A Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acquired hemophilia A Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acquired hemophilia A Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acquired hemophilia A Treatment Market Size by Type
8.2.1 Asia-Pacific Acquired hemophilia A Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acquired hemophilia A Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acquired hemophilia A Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acquired hemophilia A Treatment Market Size by Application
8.3.1 Asia-Pacific Acquired hemophilia A Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acquired hemophilia A Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acquired hemophilia A Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acquired hemophilia A Treatment Market Size by Region
8.4.1 Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acquired hemophilia A Treatment Market Size (2016-2027)
9.2 Latin America Acquired hemophilia A Treatment Market Size by Type
9.2.1 Latin America Acquired hemophilia A Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acquired hemophilia A Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acquired hemophilia A Treatment Market Size by Type (2016-2027)
9.3 Latin America Acquired hemophilia A Treatment Market Size by Application
9.3.1 Latin America Acquired hemophilia A Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acquired hemophilia A Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acquired hemophilia A Treatment Market Size by Application (2016-2027)
9.4 Latin America Acquired hemophilia A Treatment Market Size by Country
9.4.1 Latin America Acquired hemophilia A Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acquired hemophilia A Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acquired hemophilia A Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acquired hemophilia A Treatment Market Size by Type
10.2.1 Middle East & Africa Acquired hemophilia A Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acquired hemophilia A Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acquired hemophilia A Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acquired hemophilia A Treatment Market Size by Application
10.3.1 Middle East & Africa Acquired hemophilia A Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acquired hemophilia A Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acquired hemophilia A Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acquired hemophilia A Treatment Market Size by Country
10.4.1 Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Acquired hemophilia A Treatment Introduction
11.1.4 Sanofi Revenue in Acquired hemophilia A Treatment Business (2016-2021)
11.1.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acquired hemophilia A Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 200IU
Table 3. Key Players of 250IU
Table 4. Global Acquired hemophilia A Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acquired hemophilia A Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acquired hemophilia A Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acquired hemophilia A Treatment Market Share by Regions (2016-2021)
Table 8. Global Acquired hemophilia A Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acquired hemophilia A Treatment Market Share by Regions (2022-2027)
Table 10. Acquired hemophilia A Treatment Market Trends
Table 11. Acquired hemophilia A Treatment Market Drivers
Table 12. Acquired hemophilia A Treatment Market Challenges
Table 13. Acquired hemophilia A Treatment Market Restraints
Table 14. Global Acquired hemophilia A Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acquired hemophilia A Treatment Market Share by Players (2016-2021)
Table 16. Global Top Acquired hemophilia A Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired hemophilia A Treatment as of 2020)
Table 17. Ranking of Global Top Acquired hemophilia A Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acquired hemophilia A Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acquired hemophilia A Treatment Product Solution and Service
Table 21. Date of Enter into Acquired hemophilia A Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired hemophilia A Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Acquired hemophilia A Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acquired hemophilia A Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acquired hemophilia A Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Acquired hemophilia A Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acquired hemophilia A Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acquired hemophilia A Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acquired hemophilia A Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acquired hemophilia A Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acquired hemophilia A Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acquired hemophilia A Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acquired hemophilia A Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acquired hemophilia A Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acquired hemophilia A Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acquired hemophilia A Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acquired hemophilia A Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acquired hemophilia A Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acquired hemophilia A Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acquired hemophilia A Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acquired hemophilia A Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acquired hemophilia A Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acquired hemophilia A Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acquired hemophilia A Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acquired hemophilia A Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acquired hemophilia A Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acquired hemophilia A Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acquired hemophilia A Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acquired hemophilia A Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acquired hemophilia A Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acquired hemophilia A Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acquired hemophilia A Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acquired hemophilia A Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Acquired hemophilia A Treatment Product
Table 64. Sanofi Revenue in Acquired hemophilia A Treatment Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired hemophilia A Treatment Market Share by Type: 2020 VS 2027
Figure 2. 200IU Features
Figure 3. 250IU Features
Figure 4. Global Acquired hemophilia A Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Acquired hemophilia A Treatment Report Years Considered
Figure 8. Global Acquired hemophilia A Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Acquired hemophilia A Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Acquired hemophilia A Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Acquired hemophilia A Treatment Market Share by Regions (2022-2027)
Figure 12. Global Acquired hemophilia A Treatment Market Share by Players in 2020
Figure 13. Global Top Acquired hemophilia A Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired hemophilia A Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Acquired hemophilia A Treatment Revenue in 2020
Figure 15. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Acquired hemophilia A Treatment Market Share by Type (2016-2027)
Figure 19. North America Acquired hemophilia A Treatment Market Share by Application (2016-2027)
Figure 20. North America Acquired hemophilia A Treatment Market Share by Country (2016-2027)
Figure 21. United States Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acquired hemophilia A Treatment Market Share by Type (2016-2027)
Figure 25. Europe Acquired hemophilia A Treatment Market Share by Application (2016-2027)
Figure 26. Europe Acquired hemophilia A Treatment Market Share by Country (2016-2027)
Figure 27. Germany Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acquired hemophilia A Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Acquired hemophilia A Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Acquired hemophilia A Treatment Market Share by Region (2016-2027)
Figure 37. China Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acquired hemophilia A Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Acquired hemophilia A Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Acquired hemophilia A Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acquired hemophilia A Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Acquired hemophilia A Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Acquired hemophilia A Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Acquired hemophilia A Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Acquired hemophilia A Treatment Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
世界の院内感染症治療市場規模・現状・予測（2021年-2027年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 21430 million b…- 世界の血友病治療市場 2021：企業別、地域別、種類・用途別 The Hemophilia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の院内感染症（HAI）診断市場規模・現状・予測（2021年-2027年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…
- 世界の院内肺炎予防市場規模・現状・予測（2021年-2027年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…
- 世界の血友病遺伝子治療市場規模・現状・予測（2021年-2027年） Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot an…